Affix Pharmaceuticals Private Limited
About Affix Pharmaceuticals Private Limited
Data last updated:
Affix Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2015PTC284171. Its GSTIN is 07AANCA7027M1Z9 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ritesh Singh and Poonam Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 219/A Bhagat Singh Marg Kewal Park Azadpur, Delhi, India – 110033.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.81 Lakh, a decline of 34% compared to the previous year. For the same year it recorded a net loss of ₹31,836 (net margin -6.6%) and EBITDA of -₹27,800 (EBITDA margin -5.8%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 23% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Affix Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address219/A Bhagat Singh Marg Kewal Park Azadpur, Delhi, India – 110033
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Affix Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Affix Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Affix Pharmaceuticals Private Limited, buy the company report.
Financials of Affix Pharmaceuticals Private Limited
FY 2025 filings availableAffix Pharmaceuticals Private Limited reported revenue of ₹4.81 Lakh (down 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years, including a 34% fall in the latest year. EBITDA rose 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹27,800 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹31,836 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.8% | ||||
| Net Profit Margin | -6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Affix Pharmaceuticals Private Limited, buy the company report.
Board of directors and KMP of Affix Pharmaceuticals Private Limited
Affix Pharmaceuticals Private Limited currently reports 3 directors and 1 key managerial person. 4 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Singh | Director | 02 Dec 2020 | 5 Years 10 Months | Current |
| Rajnish Kumar Singh | Ceo | 07 Mar 2024 | 2 Years 7 Months | Current |
| Poonam Singh | Director | 01 Sep 2023 | 3 Years 1 Months | Current |
| Garima Singh | Director | 10 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Affix Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Debel Pharmaceuticals Private Limited | ₹4.89 Lakh (FY 2025) | -33.0% | Manika, Bihar, India | |||
| Fosto Pharmaceuticals Private Limited | ₹4.87 Lakh (FY 2025) | 44.0% | Bareilly, Uttar Pradesh, India | |||
| Affix Pharmaceuticals Private Limitedthis company | ₹4.81 Lakh (FY 2025) | -₹31,836 | -6.6% | -34.0% | Delhi, India | |
| Bransen Pharmaceuticals Private Limited | ₹4.8 Lakh (FY 2024) | New Delhi, Delhi, India | ||||
| Swift Well Pharmaceuticals Private Limited | ₹4.78 Lakh (FY 2024) | -49.0% | Deeg, Rajasthan, India |
To see the full peer comparison of Affix Pharmaceuticals Private Limited, buy the company report.
Auditor
Affix Pharmaceuticals Private Limited is audited by VIKAS MAUDGIL & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS MAUDGIL & CO. | FY 2017 | 008386C |
Shareholding
The shareholding of Affix Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Affix Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Affix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Affix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Affix Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AANCA7027M1Z9 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Affix Pharmaceuticals Private Limited, buy the company report.
Recent activity
Affix Pharmaceuticals Private Limited has 12 board changes on record since 2015: 8 appointments and 4 cessations. The latest: Rajnish Kumar Singh was appointed as CEO on 07 Mar 2024.
3 earlier events are in the company report.
Frequently asked questions
Affix Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 18 August 2015 (11+ years old) and is registered under CIN U24230DL2015PTC284171.
Affix Pharmaceuticals has 4 current directors and KMP:
- Ritesh Singh - Director
- Poonam Singh - Director
- Garima Singh - Director
- Rajnish Kumar Singh - Ceo
The latest financial statements of Affix Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Affix Pharmaceuticals is 07AANCA7027M1Z9, registered in Delhi.
The CIN (Corporate Identification Number) of Affix Pharmaceuticals is U24230DL2015PTC284171. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Affix Pharmaceuticals was incorporated on 18 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Affix Pharmaceuticals by revenue are Debel Pharmaceuticals Private Limited, Fosto Pharmaceuticals Private Limited, Bransen Pharmaceuticals Private Limited, Swift Well Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajnish Kumar Singh was appointed as CEO on 07 Mar 2024. Poonam Singh was appointed as Director on 01 Sep 2023. Garima Singh was appointed as Director on 10 Apr 2023. Affix Pharmaceuticals has 12 board changes on record in total.
The registered office of Affix Pharmaceuticals is at 219A Bhagat Singh Marg Kewal Park Azadpur, Delhi, India – 110033.
Affix Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Affix Pharmaceuticals is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.